全文获取类型
收费全文 | 1731篇 |
免费 | 83篇 |
国内免费 | 8篇 |
学科分类
医药卫生 | 1822篇 |
出版年
2024年 | 4篇 |
2023年 | 21篇 |
2022年 | 80篇 |
2021年 | 100篇 |
2020年 | 64篇 |
2019年 | 60篇 |
2018年 | 74篇 |
2017年 | 60篇 |
2016年 | 77篇 |
2015年 | 70篇 |
2014年 | 88篇 |
2013年 | 106篇 |
2012年 | 155篇 |
2011年 | 159篇 |
2010年 | 88篇 |
2009年 | 76篇 |
2008年 | 92篇 |
2007年 | 101篇 |
2006年 | 67篇 |
2005年 | 57篇 |
2004年 | 42篇 |
2003年 | 48篇 |
2002年 | 32篇 |
2001年 | 7篇 |
2000年 | 6篇 |
1999年 | 6篇 |
1998年 | 6篇 |
1997年 | 8篇 |
1996年 | 7篇 |
1995年 | 4篇 |
1994年 | 6篇 |
1993年 | 6篇 |
1992年 | 5篇 |
1990年 | 2篇 |
1989年 | 4篇 |
1988年 | 2篇 |
1987年 | 2篇 |
1986年 | 4篇 |
1985年 | 3篇 |
1984年 | 2篇 |
1983年 | 3篇 |
1982年 | 2篇 |
1981年 | 2篇 |
1980年 | 2篇 |
1979年 | 4篇 |
1976年 | 1篇 |
1973年 | 3篇 |
1971年 | 1篇 |
1969年 | 1篇 |
1968年 | 1篇 |
排序方式: 共有1822条查询结果,搜索用时 0 毫秒
31.
Azizallah Dehghan Abbas Bahrampour Gholamreza Goudarzi Masoud Yunesian 《Toxin reviews》2020,39(2):167-179
AbstractThe aim of this study was to estimate the effect of ambient air pollutants on cardiovascular deaths in Tehran, Iran. In this time series study, air pollutant data were acquired from the Environmental Protection Agency. Meteorological data were acquired from the meteorological organization, and death data were acquired from the Tehran’s cemetery registration. Generalized Additive Models (GAM) were used for estimating the Rate Ratio. NO2, SO2 and PM10 were associated with total cardiovascular deaths. PM10 and NO2 showed stronger relations with deaths in the elder age group. The result of this study showed that NO2, SO2, PM10 and O3 are probably responsible for part of the cardiovascular deaths that happen daily in Tehran. 相似文献
32.
33.
34.
35.
36.
37.
Sarraf-Zadegan N Sadri G Malek Afzali H Baghaei M Mohammadi Fard N Shahrokhi S Tolooie H Poormoghaddas M Sadeghi M Tavassoli A Rafiei M Kelishadi R Rabiei K Bashardoost N Boshtam M Asgary S Naderi G Changiz T Yousefie A 《Acta cardiologica》2003,58(4):309-320
The Isfahan Healthy Heart Programme (IHHP) is a five to six year comprehensive integrated community-based programme for cardiovascular diseases (CVD) prevention and control via reducing CVD risk factors and improvement of cardiovascular healthy behaviour in a target population. IHHP started late in 1999 and will be finished in 2005-2006. A primary survey was done to collect baseline data from interventional (Isfahan and Najaf-Abad) and reference (Arak) communities. In a two-stage sampling method, we randomly selected 5 to 10 percent of households from randomly selected clusters. Then individuals aged > or = 19 years were selected for the survey. This way, data from 12,600 individuals (6300 in interventional counties and 6300 in the reference county) was collected and stratified according to living area (urban vs. rural) and different age and sex groups. The samples underwent a 30-minute interview to complete validated questionnaires containing questions on demography, socioeconomic status, smoking behaviour, physical activity, nutritional habits and other behaviour regarding CVD. Blood pressure and body mass index (BMI) measurements were done and fasting blood samples were taken for two hours post load plasma glucose (2 hpp), serum (total, HDL and LDL) cholesterol and triglyceride levels. A twelve-lead electrocardiogram was recorded in all persons above 35 years of age. Community-wide surveillance of deaths, hospital discharges, myocardial infarction and stroke registry was carried out in the intervention and control areas. Four to five years of interventions based on different categories such as mass media, community partnerships, health system involvement and policy and legislation have started in the intervention area while Arak will be followed without intervention. Considering the results of the baseline surveys, (assessments needed, the objectives, existing resources and the possibility of national implementation) the interventions were planned. They were set based on specific target groups like school children, women, work-site, health personnel, high-risk persons, and community leaders were actively engaged as decision makers. A series of teams was arranged for planning and implementation of the intervention strategies. Monitoring will be done on small samples to assess the effect of different interventions in the intervention area. While four periodic surveys will be conducted on independent samples to assess health behaviours related to CVD risk factors in the intervention and reference areas, the original pre-intervention subjects aged more than 35 years will be followed in both areas to assess the individual effect of interventions and outcomes like sudden death, fatal and nonfatal MI and stroke. The whole baseline survey will be repeated on the original and an independent sample in both communities at the end of the study. 相似文献
38.
Mahshid Vakili Masoud Aliyali Vida Mortezaee Seyed Alireza Mahdaviani Mihan Poorabdollah Maryam Sadat Mirenayat Atefeh Fakharian Maryam Hassanzad Mahdi Abastabar Jamshid Yazdani Charati Iman Haghani Mahin Tavakoli Maedeh Maleki Darius Armstrong‐James Mohammad T. Hedayati 《The clinical respiratory journal》2020,14(8):748-757
39.
Armin Hosseini Razavi Pedram Azimzadeh Seyed Reza Mohebbi Seyed Masoud Hosseini Sara Romani Mahsa Khanyaghma Yasin Hatami Afsaneh Sharifian Mohammad Reza Zali 《Hepatitis monthly》2014,14(4)
Background:
Chronic hepatitis B is one of the world''s major health concern. The etiological agent of this infection is hepatitis B virus (HBV), which can evade the immune system response. Transforming growth factor beta 1 (TGF-β1) can act against HBV by suppressing the viral replication. The TGF-β1 also plays an important role in preventing liver damage in chronically HBV infected patients.Objectives:
In this study, the association of TGF-β1 +915G/C and -509C/T gene polymorphisms with chronic hepatitis B was evaluated in Iranian patients.Materials and Methods:
A population-based case–control study was conducted in Taleghani Hospital, Tehran. A number of 220 patients with chronic hepatitis B and the same number of healthy control subjects were designated the case and the control groups. The PCR-Restriction Fragment Length Polymorphism Method (PCR-RFLP) method was used for genotyping both polymorphisms. Ten percent of the control samples were sequenced to confirm the results.Results:
No statically significant differences in genotype distribution and allele frequency were observed for both polymorphisms between healthy controls and patients with chronic hepatitis B.Conclusions:
There was no association between TGF-β1 -509C/T and +915G/C polymorphisms with chronic hepatitis B and it seems that these changes don not play a significant role in increasing the risk of chronic infection in Iranian patients. 相似文献40.